Literature DB >> 28052821

MicroRNAs and Their Impact on Breast Cancer, the Tumor Microenvironment, and Disparities.

A Evans-Knowell1, A C LaRue2, V J Findlay3.   

Abstract

Breast cancer is a worldwide health issue as it represents the leading cause of cancer in women and the second-leading cause of cancer-related mortality in women, with an increasing incidence. Nothing speaks more clearly to the shocking breast cancer health disparities than the fact that African American (AA) women are as likely to get breast cancer as Caucasian American (CA) women, yet have a higher breast cancer death rate. It is becoming increasingly apparent that racial disparity in cancer exists due to molecular differences in tumor biology as well as, or in addition to, socioeconomic and standard of care issues (Albain, Unger, Crowley, Coltman, & Hershman, 2009). A greater understanding of the risk factors and biological links associated with breast cancer, will significantly impact AA communities due to the higher deaths associated with this disease in this population. microRNAs are small noncoding RNA molecules that were recently discovered as major players in the regulation of many diseases including cancer. Although, there are many studies that have investigated the role of miRNAs in breast cancer, few have investigated their role if any in breast cancer disparities. This review serves to summarize the current published literature that is involved in the study of microRNAs and their impact on breast cancer disparities.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cancer-associated fibroblast; Disparities; Single nucleotide polymorphisms; Tumor microenvironment; Tumor-associated macrophages; microRNA

Mesh:

Substances:

Year:  2016        PMID: 28052821      PMCID: PMC8311570          DOI: 10.1016/bs.acr.2016.08.003

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   5.767


  112 in total

1.  Changes in MicroRNA expression patterns in human fibroblasts after low-LET radiation.

Authors:  Olivier C Maes; Jin An; Harshini Sarojini; Honglu Wu; Eugenia Wang
Journal:  J Cell Biochem       Date:  2008-10-15       Impact factor: 4.429

2.  Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.

Authors:  Rebecca Siegel; Elizabeth Ward; Otis Brawley; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2011-06-17       Impact factor: 508.702

3.  Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.

Authors:  Nerea Matamala; María Teresa Vargas; Ricardo González-Cámpora; Rebeca Miñambres; José Ignacio Arias; Primitiva Menéndez; Eduardo Andrés-León; Gonzalo Gómez-López; Kira Yanowsky; Julio Calvete-Candenas; Lucía Inglada-Pérez; Beatriz Martínez-Delgado; Javier Benítez
Journal:  Clin Chem       Date:  2015-06-08       Impact factor: 8.327

4.  Macrophages as independent prognostic factors in small T1 breast cancers.

Authors:  Roberto Carrio; Tulay Koru-Sengul; Feng Miao; Stefan Glück; Omar Lopez; Yamil Selman; Consuelo Alvarez; Clara Milikowski; Carmen Gomez; Merce Jorda; Mehrad Nadji; Marta Torroella-Kouri
Journal:  Oncol Rep       Date:  2012-10-17       Impact factor: 3.906

5.  Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease?

Authors:  P A Bird; A G Hill; N Houssami
Journal:  Ann Surg Oncol       Date:  2008-04-12       Impact factor: 5.344

6.  Profile of breast cancer in a group of women in a developing country in South Asia: is there a difference?

Authors:  Menaka D S Lokuhetty; Gayani G Ranaweera; Manarangi D M Wijeratne; Kumudu H Wickramasinghe; Abdul H Sheriffdeen
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

7.  MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis.

Authors:  Chi-Hong Chao; Chao-Ching Chang; Meng-Ju Wu; How-Wen Ko; Da Wang; Mien-Chie Hung; Jer-Yen Yang; Chun-Ju Chang
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

8.  Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.

Authors:  Kathy S Albain; Joseph M Unger; John J Crowley; Charles A Coltman; Dawn L Hershman
Journal:  J Natl Cancer Inst       Date:  2009-07-07       Impact factor: 13.506

9.  Differences in the tumor microenvironment between African-American and European-American breast cancer patients.

Authors:  Damali N Martin; Brenda J Boersma; Ming Yi; Mark Reimers; Tiffany M Howe; Harry G Yfantis; Yien Che Tsai; Erica H Williams; Dong H Lee; Robert M Stephens; Allan M Weissman; Stefan Ambs
Journal:  PLoS One       Date:  2009-02-19       Impact factor: 3.240

10.  microRNA alterations in ALDH positive mammary epithelial cells: a crucial contributing factor towards breast cancer risk reduction in case of early pregnancy.

Authors:  Sushmita Bose Nandy; Ramadevi Subramani; Venkatesh Rajamanickam; Rebecca Lopez-Valdez; Arunkumar Arumugam; Thiyagarajan Boopalan; Rajkumar Lakshmanaswamy
Journal:  BMC Cancer       Date:  2014-08-31       Impact factor: 4.430

View more
  9 in total

Review 1.  Racial disparity in breast cancer: can it be mattered for prognosis and therapy.

Authors:  Vijayalaxmi Gupta; Inamul Haque; Jinia Chakraborty; Stephanie Graff; Snigdha Banerjee; Sushanta K Banerjee
Journal:  J Cell Commun Signal       Date:  2017-11-29       Impact factor: 5.782

Review 2.  Racial disparities, cancer and response to oxidative stress.

Authors:  Jie Zhang; Zhi-Wei Ye; Danyelle M Townsend; Chanita Hughes-Halbert; Kenneth D Tew
Journal:  Adv Cancer Res       Date:  2019-04-23       Impact factor: 6.242

Review 3.  Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics.

Authors:  Himadri Patel; Pritish Nilendu; Devashree Jahagirdar; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cancer Biol Ther       Date:  2017-12-08       Impact factor: 4.742

4.  Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer.

Authors:  Benfang Wang; Jianjiang Yu; Zhenjiang Sun; Frank Luh; Dandan Lin; Ying Shen; Ting Wang; Qi Zhang; Xiyong Liu
Journal:  Mol Carcinog       Date:  2020-04-29       Impact factor: 4.784

5.  MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10.

Authors:  Xiaodong Wang; Jian Lu; Jisen Cao; Bozhao Ma; Chao Gao; Feng Qi
Journal:  Onco Targets Ther       Date:  2018-11-09       Impact factor: 4.147

6.  Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients.

Authors:  Bruna M Sugita; Silma R Pereira; Rodrigo C de Almeida; Mandeep Gill; Akanksha Mahajan; Anju Duttargi; Saurabh Kirolikar; Paolo Fadda; Rubens S de Lima; Cicero A Urban; Kepher Makambi; Subha Madhavan; Simina M Boca; Yuriy Gusev; Iglenir J Cavalli; Enilze M S F Ribeiro; Luciane R Cavalli
Journal:  Oncotarget       Date:  2019-10-22

7.  Integrated Analysis of the lncRNA-Associated ceRNA Network in Wilms Tumor via TARGET and GEO Databases.

Authors:  Biao An; Yuan Hu; Xiao Liang
Journal:  Genet Res (Camb)       Date:  2022-08-31       Impact factor: 1.375

8.  The association between socioeconomic factors and breast cancer-specific survival varies by race.

Authors:  Shailesh Agarwal; Jian Ying; Kenneth M Boucher; Jayant P Agarwal
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

9.  A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer.

Authors:  Safaa Turkistani; Bruna M Sugita; Paolo Fadda; Rafael Marchi; Ali Afsari; Tammey Naab; Victor Apprey; Robert L Copeland; Michael C Campbell; Luciane R Cavalli; Yasmine Kanaan
Journal:  BMC Cancer       Date:  2021-07-27       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.